FDA — authorised 27 October 2025
- Application: ANDA219265
- Marketing authorisation holder: CARNEGIE
- Local brand name: LOMUSTINE
- Indication: CAPSULE — ORAL
- Status: approved
FDA authorised temozolomide or PCV on 27 October 2025
Yes. FDA authorised it on 27 October 2025.
CARNEGIE holds the US marketing authorisation.